GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...
The company is establishing a North Carolina factory for cold medicine as postpandemic pharma demand has grown more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback